Insider Transactions in Q1 2021 at Surface Oncology, Inc. (SURF)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Feb 16 2021	Robert W. Ross Chief Executive Officer	SELL Open market or private sale	Direct	1,000 -1.12%	$11,000 $11.35 P/Share
Feb 08 2021	Jeff Goater Director	SELL Open market or private sale	Direct	2,500 -0.95%	$30,000 $12.5 P/Share
Feb 08 2021	Jeff Goater Director	BUY Exercise of conversion of derivative security	Direct	2,500 +0.94%	$7,500 $3.18 P/Share
Feb 08 2021	Jessica Fees Chief Financial Officer	SELL Open market or private sale	Direct	1,500 -1.49%	$18,000 $12.45 P/Share
Feb 01 2021	Jessica Fees Chief Financial Officer	SELL Open market or private sale	Direct	1,500 -1.47%	$16,500 $11.19 P/Share
Feb 01 2021	Jeff Goater Director	SELL Open market or private sale	Direct	2,500 -0.95%	$25,000 $10.69 P/Share
Feb 01 2021	Jeff Goater Director	BUY Exercise of conversion of derivative security	Direct	2,500 +0.94%	$7,500 $3.18 P/Share
Jan 19 2021	Jeff Goater Director	SELL Open market or private sale	Direct	5,000 -1.87%	$65,000 $13.0 P/Share
Jan 19 2021	Jeff Goater Director	BUY Exercise of conversion of derivative security	Direct	5,000 +1.84%	$15,000 $3.18 P/Share
Jan 15 2021	Robert W. Ross Chief Executive Officer	SELL Open market or private sale	Direct	2,000 -2.2%	$24,000 $12.25 P/Share
Jan 14 2021	Robert W. Ross Chief Executive Officer	SELL Open market or private sale	Direct	7,000 -7.14%	$77,000 $11.95 P/Share

Receive a notification when an Institution or Guru buys or sells SURF shares.

Notify only if

Value

Get notified when an Surface Oncology, Inc. insider buys or sells SURF shares.

Notify only if

Operation

Value

Type

Receive news related to Surface Oncology, Inc.